æ¿åºã¯é転éå§ãã40å¹´åå¾ãã£ãå¤ãåçºãå»çãããã©ããã®å¤æãæ©æã«ç¤ºããããé»åæ¥çã«è¿ãæ±ãããå°æ¸åªåçµæ¸ç£æ¥ç¸ãé»æ°äºæ¥é£åä¼ã®å «æ¨èª ä¼é·ï¼é¢è¥¿é»å社é·ï¼ã¨17æ¥ã«ãä¼è«ãã¦è¦è«ããæ¹åã§èª¿æ´ãé²ãã§ãããå½å 48åºã®åçºã®ãã¡ãåååè¦å¶å§å¡ä¼ãé常ããå³ãã審æ»ãããèæ½åçºã¯é¢é»ç¾æµ1ã2å·
U-2 SR-71B ã¹ã«ã³ã¯ã¯ã¼ã¯ã¹ï¼Skunk worksï¼ã¯ãã¢ã¡ãªã«åè¡å½ã®èªç©ºæ©ã¡ã¼ã«ã¼ã§ãããããã¼ãã»ãã¼ãã£ã³ç¤¾ã®ä¸é¨éããããã¼ãã»ãã¼ãã£ã³å é²éçºè¨ç»ï¼Lockheed Martin's Advanced Development Programsï¼ãã®é称ã転ãã¦ãèªç©ºå®å®ä¼æ¥å ã«ãããè»äºé¢é£ã®ç§å¯éçºé¨éãè¦å¯ã®æ¦å¨åº«ã»ç«å¨ç®¡ç調æ´ã»ç¬èªè£ åéçºæ å½ãæãã¦ãããã ãã®å¾èªç¾©ãããã«æ¡å¤§ããä¼æ¥å ã®æ¥µç§éçºé¨éã»é¸æãããã¡ã³ãã¼ã®ã¿ãããªãç¹å½ãã¼ã ãªã©ããæãããã«ãªã£ã[1]ã 以ä¸ã«ã¯ãããã¼ãã»ãã¼ãã£ã³ã®ã¹ã«ã³ã¯ã¯ã¼ã¯ã¹ã«ã¤ãã¦è¨ãã è»ç¨æ©éçºã主ãªä»»åã¨ããç§å¯ãç¬ç«ãè¿ éã軸ã«ãæ°ååã®è¨è¨è ã¨ç¾æ°åã®æè½è·å¾æ¥å¡ã«ãã£ã¦æ§æããã¦ãããå代ãã¹ã¯èªç©ºæ©è¨è¨å®¶ã¯ã©ã¬ã³ã¹ã»ã¬ãªãã«ãã»ã¸ã§ã³ã½ã³ï¼Clarence Leonard Johnsonï¼
é²è¡çãã大å¦ãæ°éç 究æ©é¢ãªã©ã¨é£æºãã¦ææ°ã®è»äºæè¡éçºãè¡ãããã®åºéå¶åº¦ãåµè¨ããæ¹åã§èª¿æ´ãã¦ãããã¨ãï¼ï¼æ¥ãåãã£ããå¹³æï¼ï¼å¹´åº¦äºç®æ¦ç®è¦æ±ã§ç´ï¼ï¼ååãè¨ä¸ããè¦æ¨¡ãããã«æ¡å¤§ããæ¹éã ãåçã¯å½ééã®ç«¶äºãé«ã¾ãææ°ã®è»äºæè¡éçºã«ã¯ã大å¦ã®ç 究è½åãæ´»ç¨ãããã¨ãå¿ è¦ã¨å¤æãã¦ããããé²è¡çã¯ãèªç©ºæ©ã®æ©ä½ã«ä½¿ãæ°ç´ æãã¬ã¼ãã¼æè¡ãªã©ã®ç 究ãã¼ããå ¬è¡¨ããåºéããç 究éçºè²»ãåããã大å¦ãªã©ãåéãç 究ææã¯é²è¡çã®è£ ååéçºã«æ´»ç¨ãããããæ¥æ¬ã®è»äºæè¡éçºã¯ç¾å¨ãé²è¡ç主å°ã§é²ãããã¦ããããç 究éçºè²»ã¯ä½æ¸ç¶æ³ã«ããããã®ãããæ°éä¼æ¥ã®é²è¡äºæ¥é¨éãç 究éçºãé²ããåçå´ã«éçºææãææ¡ãããã¨ãå¤ããä¼æ¥å´ã¯éçºè²»è² æ ãå¢ãä¸æ¹ãéæå¥ç´ã§ã¯ãªããããéçºãã¦ãå注ã確å®ã«è¦è¾¼ã¾ãããç©æ¥µçãªéçºãé²ã¾ãªãã¨ããåé¡ããã£ãããããã«å¯¾ã大å¦å´ã¯ãæ±å¤§ãæ
æ¨æ¥ããã¼ãã«ç©çå¦è³ãåè³ããä¸æä¿®äºææã®è¨è ä¼è¦è¨äºãå ¬éããã¦ãã¾ããã æ¥çµæ°èï¼ä¸æææãç©çå¦è³ã§ã®åè³ã«ã¯é©ããããã¼ãã«è³ ãã®è¨äºã«ã¯ã以ä¸ã®ããã«ãè»ã®äºç®ãç²å¾ããããã«å¿ è¦ã ã£ãã®ã§ç±³å½ç±ãåå¾ããã¨ããã¾ãã --ç±³å½ç±ãåå¾ããçç±ã¯ã ããã¡ãã®å¤§å¦ã§ç 究ããä¸ã§ã¯ãç±³å½ç±ããªãã¨è»ã®äºç®ãããããªãããè»ã«é¢ä¿ããç 究ãã§ããªããããã§å¸æ°æ¨©ãåå¾ããã ç±³å½ã®å¤§å¦é¢ä¿è ã¨è©±ãã¦ããã¨è»ã®äºç®ã«é¢ãã話é¡ããã©ãã©ç»å ´ããã®ã§ãããæ¨æ¥ã®æ¥çµè¨äºãè¦ã¦ãã¦ããç±³å½ã®å¤§å¦ã«ããã¦è»ã®äºç®ãé常ã«å¤§ããªæå³ãæã£ã¦ãããã¨ãå£éè¦ããå 容ã ã¨æãã¾ããã ä¸æä¿®äºææã®è©±é¡ã«é¢é£ãã¦ãæ§ã ãªæ¹ã ãITèµ·æ¥ã«ã¤ãã¦è°è«ãã¦ããã®ã§ãããITãã¤ã³ã¿ã¼ãããã«é¢é£ãã話ã®èæ¯ã¨ãã¦ããè«å¤§ãªç±³è»é¢é£äºç®ãåå¨ãã¦ãããã¨ãå¤ãå°è±¡ã§ãã ã·ãªã³ã³ãã¬ã¼ã¨ç±³è»ã®äºç®
2014å¹´ã®ãã¼ãã«ç©çå¦è³ãåè³ããä¸æä¿®äºæ°ã¯ã2000å¹´ããç±³å½ã«ç 究ã®å ´ã移ãã¦ããã渡米ãã¦1å¹´ãçµéããä¸ææ°ã«ãç±³å½ã¨æ¥æ¬ã¨ã®éããç 究ã¸ã®åãçµã¿ã«é¢ãã¦èªã£ã¦ããã£ãï¼æ¬è¨äºã¯ãæ¥çµã¨ã¬ã¯ãããã¯ã¹ 2001å¹´4æ9æ¥å·ã«æ²è¼ããè¨äºãè¦å¢ã«é¥ãã°ãããæ°ããªã¢ã¤ãã¢ãããããåæ²ãããã®ã§ããè©æ¸ãªã©ã¯å½æã®ã¾ã¾ã§ãï¼ã ï¼èãæã¯æµ è¦ ç´æ¨¹=æ¥çµã¨ã¬ã¯ãããã¯ã¹ç·¨éé·ãå½æãï¼ éè²LEDã¨éç´«è²ã¬ã¼ã¶ã®çºæè ã1979å¹´ã«å¾³å³¶å¤§å¦å¤§å¦é¢ã®ä¿®å£«èª²ç¨ãä¿®äºããæ¥äºåå¦å·¥æ¥ã«å ¥ç¤¾ãããååç©åå°ä½ã§ããGaPï¼ã¬ãªã¦ã ãªã³ï¼ãGaAsï¼ã¬ãªã¦ã ãç´ ï¼ã®è£½é ãææããå¾ã1988å¹´ã«ç±³å½ãããªã大å¦ã«ç 究å¡ã¨ãã¦æ´¾é£ãããã帰å½å¾ã®1989å¹´ã«MOCVDè£ ç½®ã使ã£ãGaNï¼çªåã¬ãªã¦ã ï¼ç³»ææã®èä½ãã«ææ¦ãã1990å¹´ã«GaNèã®æé·ã«æåããããããã1993å¹´11æã«
é»ã£ã¦ããããã¨è¨ã£ã¦ä½ãèãã¦ããªãã£ãããã§ã¯ãªãã 5æ15æ¥ä»ãã®ã¨ã³ããªã¼ãå½ç«å¤§å¦ããã¾å¤§å¤ãªãã¨ã«ãªã£ã¦ããããæ¸ãã¦ããããããããªäººã«å¼ç¨ãããããè¨åãããããã¦ããã å½ç«å¤§å¦é¢ä¿è ãªã誰ã§ãç¥ã£ã¦ãããã¨ã ããä¸è¬ã®äººãã¡ã«ã¨ã£ã¦ã¯é©ãã¹ããã¨ã ã£ãããã§ããã ãã®å¾ãå½ç«å¤§å¦æ³äººè©ä¾¡å§å¡ä¼ãå大å¦ã«éç¥ãããå½ç«å¤§å¦æ³äººã®çµç¹åã³æ¥åå ¨è¬ã®è¦ç´ãã«é¢ããè¦ç¹ãã«ã¤ãã¦ï¼æ¡ï¼ã®çºè¡¨ãåãã¦ãæ±äº¬æ°èã9æ2æ¥ä»ãã®è¨äºãå½ç«å¤§å¦ããæç³»æ¶ããï¼ããæ²è¼ããããã¾ãã¼ãã®è¨äºãå¼ç¨ããæç°å²å¿æ°ã«ãã10æ1æ¥ä»ãLivedoorNewsã®è¨äºãå½ç«å¤§å¦ããæç³»å¦é¨ãæ¶ããï¼å®åé¦ç¸ã¨æç§çã®æåç ´å£çã大å¦æ¹é©ãããåºããã¨ã«ãã£ã¦ãã¾ãã¾ãã¼ãã®å¨è¾ºãé¨ç¶ã¨ãã¦ããããã¨æãã°ä»æå·ã®ãç¾ä»£ææ³ãã®ç¹éã¯ã大å¦å´©å£ãã¨ããã·ã§ããã³ã°ãªãã®ã ã£ããã ãããã£ã¨ç®
å¹³ç´ ã¯æ ªå¼ä¼ç¤¾ã©ã¤ããã¢ã®ãµã¼ãã¹ã ãå©ç¨ããã ããããã¨ããããã¾ãã æè¨åãã¥ã¼ã¹ãµã¤ããBLOGOSãã¯ã 2022å¹´5æ31æ¥ããã¡ã¾ãã¦ã ãµã¼ãã¹ã®æä¾ãçµäºãããã¾ããã ä¸é¨ã®ãªãªã¸ãã«è¨äºã«ã¤ãã¾ãã¦ã¯ã livedoorãã¥ã¼ã¹å ã® ãBLOGOSã®è¨äºä¸è¦§ãããã覧ããã ãã¾ãã é·ãããå©ç¨ããã ãããããã¨ããããã¾ããã ãµã¼ãã¹çµäºã«é¢ãããåãåããã¯ã ä¸è¨ã¾ã§ãé¡ããããã¾ãã ãåãåãã
â ª â ª â ª IT IT 1 12 IT IT 2001 2005 4 IT IT 2003 2005 4 1 1 3 4 6 1 2 1980 OECD 8 4 8 OECD 7 3 7 Q&A 4 5,000 5 4 OECD8 4 4 4 6 18 2 28 18 4 21 7 IT IT CD 8 IT 9 IT IT 2009 7 2015 IT i-Japan 2015 http://www.kantei.go.jp/jp/singi/it2/kettei/090706honbun.pdf EHR EHR Electronic Health Record IT 2008 10 40 74 2008 2 http://www.mhlw.go.jp/shingi/2008/01/s0130-16.html 2003 11 10 2003 2005 9 OECD 2007 5 OECD
ä¹ ä½è±äºï¼ããã¿ãããï¼ @KusumiEiji HPVã¯ã¯ãã³é¢é£ã®ãã¤ãã¿ã¼ã«ããæ°ã¥ãããã¨ï¼ï¼ï¼ï¼ãã¯ã¯ãã³ãä¸æ¢ãããã¨ãããã¤ã¼ãã¯é常ã«å¤ãããã被害è ãææ¸ãããã¨ãããã¤ã¼ãã¯ã¨ã¦ãå°ãªããããã¯ã被害è ã®ææ¸ãããã¯ã¯ãã³ä¸æ¢ãé¡ã人ã ãå¤ããã¨ã示åããããã¤ãã主ã¯ã被害è ã§ãªã誰ããã§ããå¯è½æ§ãé«ãã ä¹ ä½è±äºï¼ããã¿ãããï¼ @KusumiEiji HPVã¯ã¯ãã³é¢é£ã®ãã¤ãã¿ã¼ã«ããæ°ã¥ãããã¨ï¼ï¼ï¼ï¼ããã¿ã¹ã¯ãªããã¯ãå®æå£ä½Aã¨é¢é£ã¥ãããã¤ã¼ãããããããã¯ãéã«ãã¤ãã主ãä»ã®å®æå£ä½ã¨é¢é£ãã¦ãããã¨ã®ç¾ããï¼ãã ããå®æã«é¢é£ãã¦ã®ãã¤ããã¯å°æ°ã§ããã
ãµã¼ãã¹çµäºã®ãç¥ãã SankeiBizã¯ã2022å¹´12æ26æ¥ããã¡ã¾ãã¦ãµã¼ãã¹ãçµäºããã¦ããã ãã¾ãããé·ããã®ãæèªãèª ã«ãããã¨ããããã¾ããã ç£çµãã¸ã¿ã«ããéãããçµæ¸ãã¥ã¼ã¹ã¯ãiza! çµæ¸ãã¥ã¼ã¹ãã§ã楽ãã¿ãã ããã ãã®ãã¼ã¸ã¯5ç§å¾ã«ãiza!çµæ¸ãã¥ã¼ã¹ãï¼https://www.iza.ne.jp/economy/ï¼ã«è»¢éããã¾ãã ãã¼ã¸ãåãæ¿ãããªãå ´åã¯ä»¥ä¸ã®ãã¿ã³ãããiza! çµæ¸ãã¥ã¼ã¹ãã¸ç§»åããé¡ããã¾ãã iza! çµæ¸ãã¥ã¼ã¹ã¸
å¤ä¸ãã ãã¸ãã£ãæ¥çµå¹³å39,380.89+0.26%ãã¸ãã£ãå¤ä¸ãã ãã¬ãã£ããã¦å¹³å42,444.47-0.16%ãã¬ãã£ãå¤ä¸ãã ãã¸ãã£ãè± FTSE8,244.19+0.01%ãã¸ãã£ãå¤ä¸ãã ãã¬ãã£ãS&P500種5,782.68-0.16%ãã¬ãã£ãå¤ä¸ãã ãã¬ãã£ãUSDJPY=X148.56-0.50%ãã¬ãã£ã
ï¼»ãµã¯ã©ã¡ã³ãï¼ã«ãªãã©ã«ãã¢ï¼ãï¼ï¼æ¥ããã¤ã¿ã¼ï¼½ - ã«ãªãã©ã«ãã¢å·æé«è£ã¯ï¼ï¼æ¥ãåå·ã®é«ééé建è¨ãããããè³é調éã®ããã®åµå¸çºè¡ãèªããé«è£ã®å¤æ±ºãæ¯æããå¤æãä¸ãããå·æ¿åºã«ããæ大ï¼ï¼åãã«ã®èµ·åµã«éãéãæ ¼å¥½ã¨ãªã£ãã ã«ãªãã©ã«ãã¢å·ã¯ãµã³ãã©ã³ã·ã¹ã³ããµã¯ã©ã¡ã³ãã¨ãµã³ãã£ã¨ã´ãçµã¶ï¼ï¼ï¼ãã¤ã«ã«åã¶é«éééã®å»ºè¨ãè¨ç»ãã¦ããããä½æ°ãã建è¨è²»èª¿éã®ããã®åµå¸çºè¡é»æ¢ãç®æãã¦è¨´ããèµ·ãããã
ï¼»æ±äº¬ãï¼ï¼æ¥ããã¤ã¿ã¼ï¼½ - ã«ã¸ãéå¶ã®è§£ç¦ãç®æãè¶ å æ´¾ã®ãå½é観å ç£æ¥æ¯èè°å¡é£çãï¼é称ã«ã¸ãè°é£ï¼ã¯ï¼ï¼æ¥ååã«ç·ä¼ãéããã«ã¸ããå«ãçµ±ååãªã¾ã¼ãï¼ï¼©ï¼²ï¼ã®è§£ç¦ã«åãã第ä¸æ©ã¨ãªããæ¨é²æ³æ¡ãã«ã¤ãã¦ãï¼ï¼æ¥ã®å¹¹é¨ä¼åã§ç¢ºèªãããæ¥æ¬äººé¤å¤ãã®è¦å®ã¯çãè¾¼ã¾ããå ¥å ´æã®è¨å®ãªã©ã§å ¥å ´è ãå¶éããæ¨ãããããã¦ç¢ºèªããå ¨ä¼ä¸è´ã§äºæ¿ããã ããããå 容ãåæ ãããããæ¥æ¬äººã®å ¥å ´ã«ã¤ãã¦ã¯ãå ¥å ´æãæé¤ããã°ã©ã ãè¨ãããã¨ã§ç¯å²ã決ãããããããå¿ è¦ãªæªç½®ãè¬ãããã¨æ³æ¡ã®ä¸é¨ãä¿®æ£ããã
JXæ¥é±æ¥ç³ã¨ãã«ã®ã¼ã¯15æ¥ã2016å¹´ã«å ¨é¢èªç±åãäºå®ããã家åºåãã®é»åå°å£²ãã«åå ¥ããã¨çºè¡¨ãããèªä¸»é»æºã使ããæ°åä¸ä¸å¸¯åã«ãããé»æ°ãæ±äº¬é»å管å ã§è²©å£²ããã管å ã«æã¤ç´3000ã«æã®ã¬ã½ãªã³ã¹ã¿ã³ãããLPã¬ã¹ã®è²©å£²ç¶²ãæ´»ç¨ãããä¾¡æ ¼ç«¶äºãæ¿ãããªããã¨ãã«ãã¿ãå°å£²ããéä¿¡ãªã©ä»æ¥ç¨®ã¨ã®ææºãæ¤è¨ãã¦ããã15å¹´1æ1æ¥ä»ã§é»æ°äºæ¥é¨å ã«é»æºéçºã°ã«ã¼ãã¨é»æ°è²©å£²2ã°ã«ã¼ã
ä¸å°å液æ¶ã®ä¸çæ大æãã¸ã£ãã³ãã£ã¹ãã¬ã¤ã¯15æ¥ãã¹ãã¼ããã©ã³ï¼ã¹ããï¼åãã®é«ç²¾ç´°ããã«ãçç£ããæ·±è°·å·¥å ´ï¼å¼çç深谷å¸ï¼ã2016å¹´4æã«ééããã¨çºè¡¨ãããä¸å½ã®ã¹ããåãåºè·ãæ³å®ããå¢ããªãã£ãããã主åã®èåå·¥å ´ï¼åèçèåå¸ï¼ãªã©ã«çç£ãéç´ã競äºåãé«ããã伸ã³ãã¹ããåããå·¡ããé¢é£é¨æã®è²©å£²ç«¶äºãæ¿åãã¦ãããã¸ã£ãã³ãã£ã¹ãã¬ã¤ã¯åæ¥ã15å¹´3ææã®æçµæçãå¾æ¥äº
ï¼»ï¼ï¼æ¥ããã¤ã¿ã¼ï¼½ - ï¼ï¼æ¥ã®ç±³æ ªå¼å¸å ´ã§ãã¨ãã©åºè¡ç±ã®æææ¡å¤§ã¸ã®æ¸å¿µããèªç©ºæ ªã売ããã¦ããã ã¦ãã¤ãããã»ã³ã³ããã³ã¿ã«ã»ãã¼ã«ãã£ã³ã°ã¹ãã¢ã¡ãªã«ã³èªç©ºã°ã«ã¼ãããã«ã¿èªç©ºã®ã»ããæ ¼å®èªç©ºä¼ç¤¾ï¼ï¼¬ï¼£ï¼£ï¼ã®ã¸ã§ãããã«ã¼ãªã©ãä¸è½ãã¦ããã ãã®æ¥ã¯ããããµã¹å·ã®ç é¢ã§ã¨ãã©åºè¡ç±ã®æ£è ã®æ²»çã«å½ãã£ãçè·å¸«ã®ãã¡ï¼äººç®ãæ¤æ»ã§é½æ§åå¿ã示ãããã¨ãå¤æããã®çè·å¸«ã¯çç¶ã訴ããåæ¥ã®ï¼ï¼æ¥ãã¯ãªã¼ãã©ã³ãçºãã©ã¹ã»ãã©ã¼ãã¯ã¼ã¹è¡ãã®èªç©ºä¾¿ã«æä¹ãã¦ããã
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}